USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note C - Fair Value Measures - Schedule Of Assets And Liabilities Measured At Fair Value (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Jul. 02, 2022	Jan. 01, 2022
Foreign currency contracts included in prepaid expenses and other current assets	$ 1,435
Contingent consideration included in other current liabilities of ($338) and other long-term liabilities of ($548)	(886)
Fair Value, Net Asset (Liability), Total	160,836	$ 163,158
Foreign currency contracts included in other current liabilities		(461)
Fair Value, Inputs, Level 1 [Member]
Fair Value, Net Asset (Liability), Total	160,287	163,619
Foreign currency contracts included in other current liabilities		0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Net Asset (Liability), Total	1,435	(461)
Foreign currency contracts included in other current liabilities		(461)
Fair Value, Inputs, Level 3 [Member]
Fair Value, Net Asset (Liability), Total	(886)	0
Foreign currency contracts included in other current liabilities		0
Money Market Funds [Member]
Money market funds included in cash equivalents	160,287	163,619
Money Market Funds [Member] \| Fair Value, Inputs, Level 1 [Member]
Money market funds included in cash equivalents	160,287	163,619
Money Market Funds [Member] \| Fair Value, Inputs, Level 2 [Member]
Money market funds included in cash equivalents	0	0
Money Market Funds [Member] \| Fair Value, Inputs, Level 3 [Member]
Money market funds included in cash equivalents	$ 0	$ 0